TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
EMPLOYEES
Biogen Norway AS
Closing information (x1000 DKK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
181,334
|
168,361
|
200,902 |
| Financial expenses |
1
|
10
|
164 |
| Earnings before taxes |
9,746
|
8,084
|
6,756 |
| Total assets |
147,308
|
139,733
|
140,160 |
| Current assets |
147,171
|
139,613
|
139,976 |
| Current liabilities |
30,666
|
24,925
|
24,542 |
| Equity capital |
116,641
|
114,808
|
115,618 |
| - share capital |
63
|
66
|
71 |
| Employees (average) |
9
|
19
|
26 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
79.2%
|
82.2%
|
82.5% |
| Turnover per employee |
20,148
|
8,861
|
7,727 |
| Profit as a percentage of turnover |
5.4%
|
4.8%
|
3.4% |
| Return on assets (ROA) |
6.6%
|
5.8%
|
4.9% |
| Current ratio |
479.9%
|
560.1%
|
570.4% |
| Return on equity (ROE) |
8.4%
|
7.0%
|
5.8% |
| Change turnover |
21,425
|
-20,196
|
-71,382 |
| Change turnover % |
13%
|
-11%
|
-26% |
| Chg. No. of employees |
-10
|
-7
|
7 |
| Chg. No. of employees % |
-53%
|
-27%
|
37% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.